4.8 Article

ALKBH7 mediates necrosis via rewiring of glyoxal metabolism

Journal

ELIFE
Volume 9, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.58573

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01-HL071158]
  2. American Heart Association [19POST34380212]
  3. NIH Office of the Director [ZO1-HL002066]
  4. Medical Center, University of Rochester

Ask authors/readers for more resources

Alkb homolog 7 (ALKBH7) is a mitochondrial a-ketoglutarate dioxygenase required for DNA alkylation-induced necrosis, but its function and substrates remain unclear. Herein, we show ALKBH7 regulates dialdehyde metabolism, which impacts the cardiac response to ischemia-reperfusion (IR) injury. Using a multi-omics approach, we find no evidence ALKBH7 functions as a prolyl-hydroxylase, but we do find Alkbh7(-/-) mice have elevated glyoxalase I (GLO-1), a dialdehyde detoxifying enzyme. Metabolic pathways related to the glycolytic by-product methylglyoxal (MGO) are rewired in Alkbh7(-/-) mice, along with elevated levels of MGO protein adducts. Despite greater glycative stress, hearts from Alkbh7(-/-) mice are protected against IR injury, in a manner blocked by GLO-1 inhibition. Integrating these observations, we propose ALKBH7 regulates glyoxal metabolism, and that protection against necrosis and cardiac IR injury bought on by ALKBH7 deficiency originates from the signaling response to elevated MGO stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available